The highly expressed calciuminsensitive synaptotagmin11 and synaptotagmin13 modulate insulin secretion
For someone on Ozempic dealing with healing challenges, this combination addresses the issue from multiple angles
Therefore, using a large, real-world population with type 2 diabetes, we constructed a model to assess the cost-effectiveness of widespread use of SGLT2is and GLP-1 RAs in people with type 2 diabetes, considering only major cardiovascular and kidney outcomes
Trends in first-time prescribing First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) in December 2025 decreased, relative to September 2025 (-6.6%)
A programme designed with a time cap say, two years of coverage is providing temporary weight reduction at public expense with no lasting fiscal benefit
RIPK3, Receptor Interacting Serine/Threonine Kinase 3